Free Trial

Oncobiologics (OTLK) Insider Trading & Ownership

Oncobiologics logo
$2.07 +0.05 (+2.48%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$2.09 +0.02 (+0.97%)
As of 07/11/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Oncobiologics (NASDAQ:OTLK) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
4.80%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$28.45K
Number Of
Insiders Selling
(Last 12 Months)
0
Get OTLK Insider Trade Alerts

Want to know when executives and insiders are buying or selling Oncobiologics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

OTLK Insider Buying and Selling by Quarter

Oncobiologics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/26/2024Lawrence A KenyonCFOBuy5,000$5.69$28,450.00  
(Data available from 1/1/2013 forward)

OTLK Insider Trading Activity - Frequently Asked Questions

The list of insiders at Oncobiologics includes Jeff Evanson, Kurt J Hilzinger, Lawrence A Kenyon, Terry Dagnon, and Yezan Munther Haddadin. Learn more on insiders at OTLK.

4.80% of Oncobiologics stock is owned by insiders. Learn more on OTLK's insider holdings.

The following insiders have purchased OTLK shares in the last 24 months: Lawrence A Kenyon ($28,450.00), and Yezan Munther Haddadin ($22,245.24).

Insiders have purchased a total of 6,882 OTLK shares in the last 24 months for a total of $50,695.24 bought.

Oncobiologics Key Executives



This page (NASDAQ:OTLK) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners